Steven Cohen Soleno Therapeutics Inc Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.61 - $2.23 $161,000 - $223,000	-100,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.71 - $2.51 $1.2 Million - $1.76 Million	-700,000 Reduced 87.5%	100,000 $251,000
Q2 2020 Aug 14, 2020	BUY	$1.77 - $4.23 $734,550 - $1.76 Million	415,000 Added 107.79%	800,000 $1.78 Million
Q1 2020 May 15, 2020	BUY	$1.64 - $3.85 $631,400 - $1.48 Million	385,000 New	385,000 $916,000

550K

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $398M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.